Abstract
16 patients with transfusion-dependent, life-threatening bone marrow failure (14 with severe aplastic anaemia, 1 with systemic lupus erythematosus and 1 with pure red cell aplasia) were treated with cyclosporin-A (Cy-A) after either lack of response to conventional immunosuppression with antithymocyte-globulin/high-dose methylprednisolone for 95 to 1190 days (median 186.5) (group I, 8 patients) or as a primary treatment due to ineligibility for conventional immunosuppression (group II, 8 pat.). Cyclosporin-A was given orally to maintain trough levels of 200 to 300 ng/ml (RIA). In group I, 6 out of 8 patients responded 30 to 480 d (median 53) and are currently alive 627 to 1482 d (median 731) after initiation of Cy-A, respectively. In 3 of the responders Cy-A has been withdrawn, without relapse. In group II, 5 of 8 patients responded 26 to 170 d (median 63) and are currently alive 142 to 697 (median 420) d following initiation of Cy-A, respectively. These data indicate a place for cyclosporin-A in the management of patients with life-threatening bone marrow failure in whom a) immunosuppressive therapy with antithymocyte-globulin and high-dose methylprednisolone had failed and b) who are not candidates for vigorous immunosuppress...Continue Reading
References
Dec 3, 1977·Lancet·B SpeckJ J van Rood
Jan 1, 1986·Acta Haematologica·M Hinterberger-FischerH Niessner
Jan 1, 1988·British Journal of Haematology·A TichelliB Speck
Nov 17, 1986·Klinische Wochenschrift·N FrickhofenH Heimpel
Aug 3, 1987·Klinische Wochenschrift·P A MiescherM J Mihatsch
Sep 1, 1987·American Journal of Hematology·R BridgesW Blahey
Nov 1, 1985·Transplantation·B D Kahan
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·N C ZoumbosN S Young
Jan 1, 1985·Acta Haematologica·W HinterbergerE Kabrna
Oct 1, 1985·British Journal of Haematology·P JacobsR W Martell
Jan 20, 1983·The New England Journal of Medicine·R ChamplinR P Gale
May 1, 1983·British Journal of Haematology·J M HowsE C Gordon-Smith
Mar 8, 1984·The New England Journal of Medicine·P A StryckmansL Debusscher
Citations
Aug 1, 1990·Blut·A Raghavachar
Mar 1, 1991·American Journal of Hematology·J M CanvinJ B Johnston
May 9, 1991·The New England Journal of Medicine·N FrickhofenH Heimpel
Apr 10, 2002·International Journal of Hematology·Neal S Young
Jul 1, 1992·Annals of Hematology·H SchrezenmeierA Raghavachar
Sep 19, 2003·Wiener klinische Wochenschrift·Klaus Geissler
Apr 3, 2001·Bone Marrow Transplantation·R SafadiE Galun
Nov 8, 2005·Annals of Saudi Medicine·Jameel Al-GhazalyAdela Al-Hashdi
Sep 22, 2011·Onkologie·Philipp BaumannFuat S Oduncu
Oct 1, 1996·The Annals of Pharmacotherapy·C ColbyT R Spitzer
Jan 10, 2001·Bone Marrow Transplantation·M FouladiM H Freedman
Jan 29, 2008·International Journal of Hematology·Mamiko HattoriHaruhiko Ohashi
Dec 1, 2007·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Niranjan BiswalGinigeri Chetan
Mar 6, 1998·British Journal of Haematology·A TichelliA Gratwohl
Oct 14, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·C TagoeH M Belmont
Oct 31, 2014·Rheumatology International·Emilie ChalayerPascal Cathébras
Feb 6, 2018·Seminars in Arthritis and Rheumatism·Erik AndersonRichard Furie
Feb 17, 2000·Seminars in Hematology·J F TisdaleJ Maciejewski